By 28 January 2022, the Commission shall present a report to the European Parliament and to the Council on a feasibility study of an active substance based review system (‘monographs’) and other potential alternatives for the environmental risk assessment of veterinary medicinal products, to be accompanied, if appropriate, by a legislative proposal.
Faoin 28 Eanáir 2022, cuirfidh an Coimisiún i láthair Pharlaimint na hEorpa agus na Comhairle staidéar indéantachta córas athbhreithnithe bunaithe ar shubstaint ghníomhach (“monagraif”) agus roghanna eile chun measúnú riosca comhshaoil a dhéanamh ar tháirgí íocshláinte tréidliachta, le togra reachtach a bheith ag gabháil leis, más iomchuí.